Harae Dx Corp. Their groundbreaking technology has led to the development of the world's most compact, portable, low-cost, fast, accurate, and user-friendly automated cancer detection system. Utilizing a licensed panel of biomarkers, Harae Dx Corp.

's automated system detects breast cancer early, providing a cost-efficient and rapid cancer screening solution. Their proprietary and patented technology platform enables the detection of cancer biomarkers with unprecedented speed and efficiency, eliminating the need to send specimens to third-party laboratories. This not only decreases the potential for human processing error but also significantly reduces the result turnaround time.

Led by a team of experienced entrepreneurs, engineers, and researchers with over 25 years of expertise in AI and unicorn-related fields, Harae Dx Corp. With their visionary CEO, Rick Deckard, and talented Co-Founder and CTO, Dave Bowman, at the helm, the company is at the forefront of AI technology. Partnering with industry leaders, Harae Dx Corp.

Their non-aggressive AI approach, combined with their innovative solutions, ensures impactful and accurate cancer detection. Connect with them today to experience the future of cancer diagnostics